PRAP1

PRAP1 is an intrinsically disordered, p53-target protein that functions both as a lipid-binding co-factor facilitating apoB-containing lipoprotein assembly and as a cytoprotective factor in gastrointestinal epithelium. In the endoplasmic reticulum, PRAP1 directly binds triglyceride and forms a ternary complex with MTTP; the E85V mutation disrupts this complex and impairs MTTP-mediated lipid transfer and lipoprotein secretion (PMID:33168624). Under DNA damage, p53 induces PRAP1 transcription via response elements in PRAP1 intron 1, and PRAP1 promotes cell survival by inducing cell-cycle arrest rather than apoptosis; accordingly, Prap1-knockout mice exhibit accelerated intestinal epithelial apoptosis and lethality after total body irradiation (PMID:23235459, PMID:32629119).

1. 2010 Medium

   Establishing tissue context: PRAP1 was shown to be highly and specifically expressed in uterine luminal epithelium under hormonal regulation, placing it as an epithelium-enriched, hormonally responsive gene whose function was otherwise unknown.

   Evidence mRNA expression profiling in ovariectomized mouse uterus with progesterone and estrogen treatments

   PMID:20674898

   Open questions at the time

   • No functional consequence of PRAP1 loss or gain in the uterus was demonstrated
   • Mechanism by which steroid hormones regulate PRAP1 transcription was not defined
   • No protein-level validation of PRAP1 expression dynamics
2. 2012 High

   Identifying the transcriptional regulator and cytoprotective role: p53 was shown to directly bind response elements in PRAP1 intron 1 and upregulate PRAP1 upon DNA damage, and PRAP1 knockdown revealed that the protein promotes cell survival by favoring cell-cycle arrest over apoptosis.

   Evidence ChIP assay for p53 occupancy at PRAP1 intron 1; siRNA knockdown with apoptosis and viability assays after chemotherapeutics, gamma irradiation, and H₂O₂ in human cancer cell lines

   PMID:23235459

   Open questions at the time

   • Molecular mechanism by which PRAP1 induces cell-cycle arrest was not identified
   • In vivo relevance of the cytoprotective function was not yet tested
   • Downstream effectors or signaling pathways linking PRAP1 to arrest versus apoptosis decision were unknown
3. 2020 High

   In vivo validation of the cytoprotective role and structural characterization: Prap1-knockout mice demonstrated accelerated intestinal epithelial apoptosis and death after irradiation, confirming PRAP1 as a gastrointestinal barrier protector, and biochemical characterization established PRAP1 as an intrinsically disordered protein.

   Evidence Prap1-/- mouse model with total body irradiation challenge; ex vivo enteroid irradiation assay; recombinant PRAP1 biophysical characterization

   PMID:32629119

   Open questions at the time

   • Direct molecular target or binding partner mediating the anti-apoptotic function in intestinal epithelium was not identified
   • Relationship between intrinsic disorder and function remains uncharacterized
4. 2020 High

   Revealing a second major function — lipid transport: PRAP1 was identified as a triglyceride-binding protein that forms a ternary complex with TG and MTTP in the ER, directly facilitating apoB-containing lipoprotein assembly and secretion, as proven by the E85V mutation that disrupts ternary complex formation.

   Evidence In vitro lipid-binding assays, ER co-fractionation, site-directed mutagenesis (E85V), lipoprotein secretion assays in PRAP1-deficient and E85V knock-in mice

   PMID:33168624

   Open questions at the time

   • Structural basis for how an intrinsically disordered protein binds TG and MTTP simultaneously is unknown
   • Whether the lipid-transport and cytoprotective functions are mechanistically linked is untested
   • Physiological consequences of impaired lipoprotein assembly in PRAP1-deficient mice under dietary challenge were not fully characterized

• It remains unknown how PRAP1's intrinsically disordered structure enables dual functions in lipid transport and anti-apoptotic signaling, and whether these represent independent or coordinated activities in intestinal epithelium.
• No structural model explaining how PRAP1 engages both MTTP/TG and cell-cycle arrest pathways
• Direct downstream effectors of the anti-apoptotic function have not been identified
• Functional relevance of PRAP1 in uterine biology remains untested beyond expression data